Randy Cron
University of Alabama at Birmingham
H-index: 67
North America-United States
Top articles of Randy Cron
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Anakinra at the heart of the matter in MIS-C | Daniel D Reiff Randy Q Cron | 2024/2/1 | |
Role of DOCK8 in Hyper-inflammatory Syndromes | medRxiv | Mingce Zhang Remy R Cron Niansheng Chu Junior Nguyen Scott M Gordon | 2024 |
Cytokine storm syndrome | Randy Q Cron Gaurav Goyal W Winn Chatham | 2023/1/27 | |
DOCK2 Mutation and Recurrent Hemophagocytic Lymphohistiocytosis | Life | Daniel D Reiff Mingce Zhang Randy Q Cron | 2023/2/3 |
Childhood‐onset lupus nephritis in the Childhood Arthritis and Rheumatology Research Alliance Registry: Short‐term kidney status and variation in care | Arthritis Care & Research | Emily A Smitherman Rouba A Chahine Timothy Beukelman Laura B Lewandowski AKM Fazlur Rahman | 2023/7 |
Majority of new patient referrals to a large pediatric rheumatology center result in non-rheumatic diagnosis | Pediatric Rheumatology | Daniel D Reiff John M Bridges Eileen C Rife Victoria L Gennaro Linda McAllister | 2023/10/13 |
Double-barrel targeting of IFN-γ to treat hemophagocytic lymphohistiocytosis | Journal of Allergy and Clinical Immunology | Randy Q Cron | 2023/1/1 |
Immunologic prediction of long COVID | Nature Immunology | Randy Q Cron | 2023/2 |
Cytokine storm syndrome triggered by extracorporeal membrane oxygenation in pediatric patients | Children | Daniel D Reiff Randy Q Cron | 2023/6/13 |
The 2022 EULAR/ACR points to consider at the early stages of diagnosis and management of suspected haemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/MAS) | Annals of the Rheumatic Diseases | Bita Shakoory Ashley Geerlinks Marta Wilejto Kate Kernan Melissa Hines | 2023/10/1 |
Management of orofacial manifestations of juvenile idiopathic arthritis: Interdisciplinary consensus‐based recommendations | Peter Stoustrup Cory M Resnick Shelly Abramowicz Thomas K Pedersen Ambra Michelotti | 2023/1 | |
Anti-FHL1 autoantibodies in juvenile myositis are associated with anti-Ro52 autoantibodies but not with severe disease features | Rheumatology | Matthew A Sherman Rose Graf Sara E Sabbagh Angeles S Galindo-Feria Iago Pinal-Fernandez | 2023/2/1 |
Prediction of Survival by IL-6 in a Randomized Placebo-Controlled Trial of Anakinra in COVID-19 Cytokine Storm | Viruses | Lesley E Jackson Nitasha Khullar Timothy Beukelman Chris Chapleau Abhishek Kamath | 2023/9/30 |
The multifaceted immunology of cytokine storm syndrome | Pui Y Lee Randy Q Cron | 2023/4/15 | |
Trajectories of disease activity in patients with JIA in the Childhood Arthritis and Rheumatology Research Alliance Registry | Rheumatology | Natalie J Shiff Peter Shrader Colleen K Correll Anne Dennos Thomas Phillips | 2023/2/1 |
Disease recapture rates after medication discontinuation and flare in juvenile idiopathic arthritis: an observational study within the childhood arthritis and rheumatology … | Arthritis Care & Research | Sarah Ringold Anne C Dennos Yukiko Kimura Timothy Beukelman Peter Shrader | 2023/4 |
Autoantibodies Recognizing Specificity Protein 4 Co‐occur With Anti–Transcription Intermediary Factor 1 and Are Associated With Distinct Clinical Features and Immunogenetic … | Arthritis & Rheumatology | Matthew A Sherman Katherine Pak Iago Pinal‐Fernandez Willy A Flegel Ira N Targoff | 2023/9 |
Dosing variation at initiation of adalimumab and etanercept and clinical outcomes in juvenile idiopathic arthritis: a Childhood Arthritis and Rheumatology Research Alliance … | Arthritis Care & Research | Ruud HJ Verstegen Peter Shrader Stephen J Balevic Timothy Beukelman Colleen Correll | 2023/2 |
Janus kinase inhibition in juvenile idiopathic arthritis | The Lancet | Eileen C Rife Randy Q Cron | 2023/8/12 |
To Wean or Not to Wean: That is the Question. | Arthritis Care & Research | Melissa L Mannion Randy Q Cron | 2023/4/1 |
